Confirming the efficacy of intravenous immunoglobulin in CIDP through minimum clinically important differences: shifting from statistical significance to clinical relevance.


BACKGROUND The ICE trial demonstrated the efficacy of immune globulin intravenous (IGIV-C) over placebo in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). However, improving the interpretability of the results by analysing the minimum clinically important difference (MCID) had not been considered. OBJECTIVES To identify MCID thresholds… (More)
DOI: 10.1136/jnnp.2009.194324


4 Figures and Tables

Slides referencing similar topics